Emicizumab is under clinical development by Chugai Pharmaceutical and currently in Phase I for Von Willebrand Disease (vWD).

VWD is the most common inherited bleeding disorder, affecting up to 1% of the global population, and is caused by deficiency or dysfunction in the protein known as von Willebrand factor (VWF).

and VWD (Frankfurt). In 2009, he co-founded Press+, which was acquired by RR Donnelley in 2011. He is a member of the board of directors of Blurb, Business Insider, Houghton Mifflin Harcourt ...

108228804 Genetic mutations: Inherited bleeding disorders like hemophilia and VWD are caused by genetic mutations that affect the production or function of clotting factors. Liver disease: The liver ...

Emicizumab is under clinical development by Chugai Pharmaceutical and currently in Phase II for Acquired Hemophilia A.

The Vanquish Core systems have been built to utilize a wide range of analytical detectors, including mass spectrometry (MS), diode array detection (DAD), multi wavelength detection (MWD), charged ...

The Kansas City Chiefs are in a dogfight with their hated rival, the Cincinnati Bengals, but the Chiefs took the lead in the third quarter in the funniest way.